Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: Evidence for systemic activation of the T cell compartment

Leukemia Research

Volumn 22, Issue 2, 1998, Pages 175-184

  Van Den Hove, Ludwig E ^a   Vandenberghe, Peter ^a   Van Gool, Stefaan W ^b   Ceuppens, Jan L ^b   Demuynck, Hilde ^a   Verhoef, Gregor E G ^a   Boogaerts, Marc A ^a  

^a University of Leuven   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Correlation biplot; Cytotoxic T lymphocytes; Immunosurveillance; Lymphocyte subsets; Multivariate analysis; Neoplasia

Indexed keywords

CD16 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; PADGEM PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHATIC LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0032006459     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00152-5     Document Type: Article

References (29)

1. 1. Boon, T., Toward a genetic analysis of tumor rejection antigens. Advances in Cancer Research, 1992, 58, 177.
2. 2. Urban, J. L. and Schreiber, H., Tumor antigens. Annual Review of Immunology, 1992, 10, 617.
3. 3. Ostrand-Rosenberg, S., Tumor immunotherapy: the tumor as an antigen-presenting cell. Current Opinion in Immunology, 1994, 6, 722.
4. 4. Prehn, R. T., Stimulatory effects of immune reactions upon the growths of untransplanted tumors. Cancer Research, 1994, 54, 908.
5. 5. Chakrabarti, D. and Ghosh, S. K., Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor I. Role of idiotypic immunoglobulin. Cellular Immunology, 1992, 142, 54.
6. 6. Janson, C. H., Grunewald, J., Österborg, A., DerSimonian, H., Brenner, M. B., Mellstedt, H. and Wigzell, H., Predominant T cell receptor V gene usage in patients with abnormal clones of B cells. Blood, 1991, 77, 1776.
7. 7. Farace, F., Orlanducci, F., Dietrich, P.-Y., Gaudin, C., Angevin, E., Courtier, M.-H., Bayle, C., Hercend, T. and Triebel, F., T cell repertoire in patients with B chronic lymphocytic leukemia. Journal of Immunology, 1994, 153, 4281.
8. 8. Serrano, D., Monteiro, J., Allen, S. L., Kolitz, J., Schulman, P., Lichtman, S. M., Buchbinder, A., Vinciguerra, V. P., Chiorazzi, N. and Gregersen, P. K., Clonal expansion within the CD4 + CD57 + and CDS + CD57 + T cell subsets in chronic lymphocytic leukemia. Journal of Immunology, 1997, 158, 1482.
9. 9. Van den Hove, L.E., Symons, F., Vandenberghe, P., Verhoef, G. E. G., Demuynck, H., Van Gool, S. W., Ceuppens, J. L. and Boogaerts, M. A., Multivariate reconstruction of lymphocyte profiles in a two-dimensional graphical model as a tool for the investigation of lymphocyte subset distribution in health and disease. Cytometry, 1997, 28, 220.
10. 10. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. C., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Muller-Hermelink, H.-K., Pileri, S. A., Piris, M. A., Ralfkiaer, E. and Warnke, R. A., A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 1994, 84, 1361.
11. 11. Lee, G. R., Bithell, T. C., Foerster, J., Athens, J. W. and Lukens, J. N. (Eds). Wintrobe's Clinical Hematology, 9th edn, Vol. 2. Lea and Febiger, Philadelphia, 1993, pp. 1875-1878, 1949-1951.
12. 12. Durie, B. G. M. and Salmon, S. E., A clinical staging system for multiple myeloma. Cancer, 1975, 36, 842.
13. 13. Leeuwenberg, J. F. M., Spits, H., Tax, W. J. M, and Capel, P. J. A., Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies. Journal of Immunology, 1985, 134, 3770.
14. 14. Van Gool, S. W., de Boer, M. and Ceuppens, J. L., CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. Journal of Immunology, 1993, 150, 3254.
15. 15. Reichert, T., DeBruyère, M., Deneys, V., Tötterman, T., Lydyard, P., Yuksel, F., Chapel, H., Jewell, D., Van Hove, L., Linden, J. and Buchner, L., Lymphocyte subset ranges in adult Caucasians. Clinical Immunology and Immunopathology, 1991, 60, 190.
16. 16. Sansoni, P., Cossarizza, A., Brianti, V., Fagnoni, F., Snelli, G., Monti, D., Marcato, A., Passeri, G., Ortolani, C., Forti, E., Fagiolo, U., Passeri, M. and Franceschi, C., Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood, 1993, 82, 2767.
17. 17. Ruiz, M., Esparza, B., Pérez, C., Barranquero, M., Sabino, E. and Merino, F., CD8 + T cell subsets in aging. Immunological Investigations, 1995, 24, 891.
18. 18. Ko, H.-S., Fu, S.M., Winchester, R.J., Yu, D.T.Y. and Kunkel, H.G., Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen-and antigen-activated T cells. Journal of Experimental Medicine, 1979, 150, 246.
19. 19. Kern, F., Ode-Hakim, S., Vogt, K., Höflich, C., Reinke, P. and Volk, H.D., The enigma of CD57 + CD28-T cell expansion - anergy or activation? Clinical and Experimental Immunology, 1996, 104, 180.
20. 20. Kanof, M. E. and James, S. P., Leu-8 antigen expression is diminished during cell activation but does not correlate with effector function of activated T lymphocytes. Journal of Immunology, 1988, 140, 3701.
21. - T lymphocytes.Antigenic and functional properties. Journal of Immunology, 1993, 150, 1147.
22. 22. Miguel-Garcia, A., Matutes, E., Tarin, F., Garcia-Talavera, J., Miguel-Sosa, A., Carbonell, F. and Catovsky, D., Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy. Journal of Clinical Pathology, 1995, 48, 835.
23. 23. Posner, M. R., Elboim, H. S., Tumber, M. B. and Cannon, T. J., Human monoclonal antibodies reactive with cell surface antigens on human leukemia cell lines: many antibodies are (auto) antibodies. Hybridoma, 1990, 9, 97.
24. 24. Punt, C. J. A., Barbuto, J. A. M., Zhang, H., Grimes, W. J., Hatch, K. D. and Hersh, E. M., Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes. Cancer Immunology and Immunotherapy, 1994, 38, 225.
25. 25. Vanky, F., Klein, E., Willems, J., Böök, K., Ivert, T., Peterffy, A., Nilsonne, U., Kreicbergs, A. and Aparisi, T., Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Cancer Immunology and Immunotherapy, 1986, 21, 69.
26. 26. Kedar, E. and Klein, E., Cancer immunotherapy: are the results discouraging? Can they be improved? Advances in Cancer Research, 1992, 59, 245.
27. 27. Vegh, Z. S., Wang, P., Vanky, F. and Klein, E., Selectively downregulated expression of MHC Class I alleles in human solid tumors. Cancer Research, 1993, 53, 2416.
28. 28. Dianzani, U., Pileri, A., Boccadoro, M., Palumbo, A., Pioppo, P., Bianchi, A., Camponi, A., Battaglio, S. and Massaia, M., Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. Blood, 1988, 72, 1064.
29. 29. Diaz, J. I., Edinger, M. G., Stoler, M. H. and Tubbs, R. R., Activated T cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas. American Journal of Pathology, 1991, 139, 503.